was read the article
array:24 [ "pii" => "S2173511515002055" "issn" => "21735115" "doi" => "10.1016/j.rppnen.2015.12.002" "estado" => "S300" "fechaPublicacion" => "2016-05-01" "aid" => "1121" "copyright" => "Sociedade Portuguesa de Pneumologia" "copyrightAnyo" => "2015" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "cor" "cita" => "Rev Port Pneumol. 2016;22:183" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1456 "formatos" => array:3 [ "EPUB" => 195 "HTML" => 754 "PDF" => 507 ] ] "itemSiguiente" => array:18 [ "pii" => "S2173511515001864" "issn" => "21735115" "doi" => "10.1016/j.rppnen.2015.10.006" "estado" => "S300" "fechaPublicacion" => "2016-05-01" "aid" => "1106" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "cor" "cita" => "Rev Port Pneumol. 2016;22:184" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1488 "formatos" => array:3 [ "EPUB" => 203 "HTML" => 762 "PDF" => 523 ] ] "en" => array:9 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "COPD: Are we using all the tools we have?" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "184" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "A. Araújo" "autores" => array:1 [ 0 => array:2 [ "nombre" => "A." "apellidos" => "Araújo" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173511515001864?idApp=UINPBA00004E" "url" => "/21735115/0000002200000003/v1_201605310123/S2173511515001864/v1_201605310123/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2173511516000099" "issn" => "21735115" "doi" => "10.1016/j.rppnen.2016.01.002" "estado" => "S300" "fechaPublicacion" => "2016-05-01" "aid" => "1132" "copyright" => "Sociedade Portuguesa de Pneumologia" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "cor" "cita" => "Rev Port Pneumol. 2016;22:181-2" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1307 "formatos" => array:3 [ "EPUB" => 193 "HTML" => 624 "PDF" => 490 ] ] "en" => array:9 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Research Letter</span>" "titulo" => "Critical appraisal of the Portuguese clinical guideline 28/2011" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "181" "paginaFinal" => "182" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "T. Sousa-Veloso" "autores" => array:1 [ 0 => array:2 [ "nombre" => "T." "apellidos" => "Sousa-Veloso" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173511516000099?idApp=UINPBA00004E" "url" => "/21735115/0000002200000003/v1_201605310123/S2173511516000099/v1_201605310123/en/main.assets" ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Clinical trials in Portugal: A ruby in the middle of the rubble" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "183" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "J.C. Winck" "autores" => array:1 [ 0 => array:3 [ "nombre" => "J.C." "apellidos" => "Winck" "email" => array:1 [ 0 => "jcwinck@mail.telepac.pt" ] ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Faculty of Medicine, Porto University, Portugal" "identificador" => "aff0005" ] ] ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 934 "Ancho" => 1591 "Tamanyo" => 84043 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Clinical trials in COPD including Portuguese centres (2006–2015).</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">The decrease in the number of clinical trials held in Portugal shows a loss of competiveness that is disturbing. We should focus on measures that may recover the implementation of a dynamic clinical investigation field.</p><p id="par0010" class="elsevierStylePara elsevierViewall">According to a study of the Portuguese Association of Pharmaceutical Industry (APIFARMA) published in 2013<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> there has been a tendency towards stagnation in the number of Clinical trials (CT) in Portugal. Nevertheless, in 2012 the market value of CT in Portugal was €36 millions. Looking at the sites where the CT were performed, between 2006 and 2011, Coimbra University Hospital Centre (CHUC) with 158 CT, North Lisbon Hospital Centre (CHLN) with 135 and São João Hospital Centre (CHSJ) with 98 were the top 3 institutions.</p><p id="par0015" class="elsevierStylePara elsevierViewall">Compared to Cardiology with 34 CT from 2009 until 2012, Pulmonology had only 15. Compared with other countries, in 2010 Portugal had one of the lowest numbers of CT per million inhabitants, with 10 compared with Czech Republic, which achieved 47.<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">2</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">Recently the EU has developed a register for all the Clinical trials performed in Europe.<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">3</span></a> Analysing the participation of Portuguese centres in the area of Pulmonology from 2006 to 2015, the scenario is also not very optimistic, with a total of 15 trials on COPD, 7 in Cystic Fibrosis (CF), 55 in Lung Cancer (LC) and 6 in Idiopathic Pulmonary Fibrosis (IPF). This is a long way from the involvement of Greece and the Czech Republic with, respectively, 28 and 68 CT on COPD, 4 and 13 CT on CF, 77 and 107 on LC and 6 and 12 on IPF. Moreover, analysing the participation of Portuguese centres in CT on COPD (a disease with the highest number of patients included in CT) over the last 10 years (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>), there is an irregular pattern with a minimum of 0 in 2012 and a maximum of 4 in 2014.</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0025" class="elsevierStylePara elsevierViewall">What can we do to improve?</p><p id="par0030" class="elsevierStylePara elsevierViewall">By doing Clinical trials we will generate better quality data to support our decisions in healthcare.</p><p id="par0035" class="elsevierStylePara elsevierViewall">Scientific societies should have a stronger commitment to the promotion and support of the clinical investigation in Portugal. By helping to network with European countries it will facilitate internationalization and improvement in science.</p><p id="par0040" class="elsevierStylePara elsevierViewall">Through the creation of dedicated structures and enhancement of cooperation between Portuguese centres the results will appear in the future.</p><p id="par0045" class="elsevierStylePara elsevierViewall">Models that include incentives for the participation of researchers and other medical professionals should be common practice. Investigator-driven CT should be also encouraged and welcomed.</p><p id="par0050" class="elsevierStylePara elsevierViewall">If we succeed in improving these figures, the Portuguese economy will be stronger, we will increase our small footprint in the European respiratory science and our specialty will have a higher profile.</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Conflicts of interest</span><p id="par0055" class="elsevierStylePara elsevierViewall">The authors have no conflicts of interest to declare.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:2 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Conflicts of interest" ] 1 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "multimedia" => array:1 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 934 "Ancho" => 1591 "Tamanyo" => 84043 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Clinical trials in COPD including Portuguese centres (2006–2015).</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:3 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:1 [ "titulo" => "Study on Clinical trials in Portugal" ] ] "host" => array:1 [ 0 => array:1 [ "Libro" => array:2 [ "fecha" => "2013" "editorial" => "Associação Portuguesa da Indústria Farmacêutica (APIFARMA)" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0020" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "APIFARMA, Desafios da Saúde em Portugal 2013, 20 Março" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "Price Waterhouse Coopers" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Libro" => array:1 [ "fecha" => "2013" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0025" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "EU Clinical Trials Register. <a id="intr0015" class="elsevierStyleInterRef" href="https://www.clinicaltrialsregister.eu/ctr-search/search">https://www.clinicaltrialsregister.eu/ctr-search/search</a>." ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/21735115/0000002200000003/v1_201605310123/S2173511515002055/v1_201605310123/en/main.assets" "Apartado" => array:4 [ "identificador" => "20584" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letters to the Editor" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/21735115/0000002200000003/v1_201605310123/S2173511515002055/v1_201605310123/en/main.pdf?idApp=UINPBA00004E&text.app=https://journalpulmonology.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173511515002055?idApp=UINPBA00004E" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 5 | 2 | 7 |
2024 October | 39 | 37 | 76 |
2024 September | 50 | 25 | 75 |
2024 August | 61 | 29 | 90 |
2024 July | 42 | 35 | 77 |
2024 June | 33 | 25 | 58 |
2024 May | 31 | 36 | 67 |
2024 April | 31 | 32 | 63 |
2024 March | 28 | 24 | 52 |
2024 February | 26 | 25 | 51 |
2024 January | 27 | 33 | 60 |
2023 December | 20 | 25 | 45 |
2023 November | 31 | 79 | 110 |
2023 October | 25 | 31 | 56 |
2023 September | 22 | 35 | 57 |
2023 August | 20 | 17 | 37 |
2023 July | 27 | 28 | 55 |
2023 June | 26 | 22 | 48 |
2023 May | 36 | 28 | 64 |
2023 April | 13 | 13 | 26 |